Melisron Ltd
TASE:MLSR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.2), the stock would be worth ₪34 448.16 (22% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.6 | ₪44 250 |
0%
|
| 3-Year Average | 1.2 | ₪34 448.16 |
-22%
|
| 5-Year Average | 1.3 | ₪35 163.41 |
-21%
|
| Industry Average | 1.4 | ₪38 187.7 |
-14%
|
| Country Average | 2.3 | ₪63 516.81 |
+44%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| IL |
M
|
Melisron Ltd
TASE:MLSR
|
21B ILS | 1.6 | 11.3 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
308.8B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 1 319.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.4B ZAR | 1.1 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.5B USD | 1 973.5 | 38 690 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
55.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
37.6B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.8B USD | 53.7 | -3 284.6 | |
| US |
|
Coupang Inc
F:788
|
31.5B EUR | 7.8 | 174.3 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
30.1B ZAR | 1 | 6.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.3 |
| 70th Percentile | 4.2 |
| Max | 1 400.5 |
Other Multiples
Melisron Ltd
Glance View
Melisron Ltd., a significant player in the Israeli real estate landscape, has been sculpting urban experiences through its premier commercial properties. Established with the vision of enhancing urban prosperity, Melisron manages and develops a diversified portfolio of shopping centers and office spaces strategically located across Israel. By blending modern architectural designs with consumer-centric offerings, Melisron breathes vitality into urban life. Shopping centers like the Grand Canyon in Haifa and other high-profile locations are not merely retail spaces but bustling hubs that drive footfall through an array of shopping, dining, and entertainment options. These centers are ingeniously crafted to link communities with prominent retail brands while providing tenants with a dynamic platform to reach diverse demographics. The company’s financial success is primarily anchored in generating rental income from its expansive property portfolio. Melisron’s business model thrives on long-term leases with renowned national and international retail chains, ensuring a steady cash flow. Their strategic management involves not only acquiring prime real estate but also continually enhancing tenant mix to adapt to emerging market trends and consumer preferences. By fostering relationships with retailers and investing in cutting-edge infrastructure, Melisron boosts property value while maintaining high occupancy rates. This approach allows Melisron to benefit from stable rental yields and appreciate asset values, reinforcing its position as a leader in Israel's commercial real estate arena.